Leads Biolabs

Leads Biolabs is a pharmaceutical company that develops medicines and treatments for tumors.

Number of Funding Rounds

Total Funding Amount

6

$100M

Leads Biolabs has raised a total of $100M in funding over 2 rounds. Their latest funding was raised on Oct 8, 2021 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 8, 2021	Series C	$100M	8	—	—	Detail
Oct 28, 2020	Series Unknown	—	7	—	—	Detail
Apr 18, 2019	Series Unknown	—	2	—	—	Detail
Aug 29, 2018	Series B	—	1	—	—	Detail
Jul 3, 2017	Series A	—	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

14

Leads Biolabs is funded by 14 investors. Beijing Hankang Chuangye Touzi and Enran Chuangtou are the most recent investors.

Investor Name	Lead Investor	Funding Round
Beijing Hankang Chuangye Touzi	—	Series C
Enran Chuangtou	—	Series C
Zhenji Capital	—	Series C
Anjie Zhengjuan	—	Series C
Gansu New Silk Road Industrial Investment	—	Series C
Rongchang Chuangtou	—	Series C
Zhuang Zhong Chuang Tou	—	Series C
Huaige Capital	—	Series C
Minglang Capital	—	Series Unknown
Guohong Chuangtou	—	Series Unknown